These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 18756458

  • 1. Long-term outcome of mycophenolate mofetil rescue therapy for resistant acute allograft rejection in pediatric liver transplant recipients.
    Aw MM, Verma A, Rela M, Heaton N, Mieli-Vergani G, Dhawan A.
    Liver Transpl; 2008 Sep; 14(9):1303-8. PubMed ID: 18756458
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil in pediatric heart transplant recipients: a single-center experience.
    Dipchand AI, Benson L, McCrindle BW, Coles J, West L.
    Pediatr Transplant; 2001 Apr; 5(2):112-8. PubMed ID: 11328549
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil in liver transplantation.
    McDiarmid SV.
    Clin Transplant; 1996 Feb; 10(1 Pt 2):140-5. PubMed ID: 8680052
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil for renal dysfunction after pediatric liver transplantation.
    Evans HM, McKiernan PJ, Kelly DA.
    Transplantation; 2005 Jun 15; 79(11):1575-80. PubMed ID: 15940048
    [Abstract] [Full Text] [Related]

  • 9. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan 27; 65(2):235-41. PubMed ID: 9458021
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range.
    Tredger JM, Brown NW, Adams J, Gonde CE, Dhawan A, Rela M, Heaton N.
    Liver Transpl; 2004 Apr 27; 10(4):492-502. PubMed ID: 15048791
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of mycophenolate mofetil as rescue therapy after pediatric liver transplantation.
    Chardot C, Nicoluzzi JE, Janssen M, Sokal E, Lerut J, Otte JB, Reding R.
    Transplantation; 2001 Jan 27; 71(2):224-9. PubMed ID: 11213063
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial.
    Sterneck M, Fischer L, Gahlemann C, Gundlach M, Rogiers X, Broelsch C.
    Ann Transplant; 2000 Jan 27; 5(1):43-6. PubMed ID: 10850611
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of low-dose mycophenolate mofetil therapy for Taiwanese renal transplantation patients receiving primary cyclosporine immunosuppression.
    Tsai MK, Hu RH, Lee CJ, Lee PH.
    J Formos Med Assoc; 2002 Sep 27; 101(9):616-21. PubMed ID: 12645188
    [Abstract] [Full Text] [Related]

  • 20. Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection.
    Boratyńska M, Banasik M, Patrzałek D, Klinger M.
    Ann Transplant; 2006 Sep 27; 11(2):51-6. PubMed ID: 17494290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.